Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > PR today?

<< Previous

Bullboard Posts

Next >>

Post by lonc17on Jun 03, 2023 2:44pm

262 Views

Post# 35478584

PR today?

I beileve that if the data are strong (as strongly hinted at by MC) then ONC will issue a rare Saturday press release with a link to their posters page.

If the data are not strong (as has always been the case) then ONC will wait till Monday morning in so as to allow them an oppotunity to "convince" the public that the ambiguous results are of great interest

The longer we wait, the less likely the results are stellar.

<< Previous

Bullboard Posts

Next >>

Events and communications company provides activity update